Literature DB >> 2429187

Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.

W E Collins, R F Anders, M Pappaioanou, G H Campbell, G V Brown, D J Kemp, R L Coppel, J C Skinner, P M Andrysiak, J M Favaloro.   

Abstract

Recent studies have identified and characterized a ring-infected erythrocyte surface antigen (RESA) of the human malaria parasite Plasmodium falciparum with a relative molecular mass (Mr) of approximately 155,000 (refs 1-7). RESA is localized in the micronemes of merozoites and also the membrane of red cells infected with ring-stage parasites. It is thought to be released through the apical pore from the rhoptry at the time of merozoite invasion. Because antibodies directed against this antigen strongly inhibit parasite growth in vitro, RESA may be useful in developing a vaccine against this parasite Here we describe an immunization trial using Aotus monkeys and Escherichia coli-derived fused polypeptides corresponding to various regions of the RESA molecule. Some monkeys in all test groups, but not in the control group, were protected against overwhelming infection. Strikingly, protection correlated with antibody responses to either of two different repetitive sequences in RESA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429187     DOI: 10.1038/323259a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  45 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Isolation of peptides that mimic epitopes on a malarial antigen from random peptide libraries displayed on phage.

Authors:  C G Adda; L Tilley; R F Anders; M Foley
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Isolation and serological characterization of a Plasmodium vivax recombinant antigen.

Authors:  Y D Sharma; V P Sharma; P Ray; S Laal; S D Sawant; S Verma
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1.

Authors:  Karen S Harris; Joanne L Casey; Andrew M Coley; Rosella Masciantonio; Jennifer K Sabo; David W Keizer; Erinna F Lee; Andrew McMahon; Raymond S Norton; Robin F Anders; Michael Foley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  A monoclonal antibody to Ly-6 gene product inhibits generation of functionally active T cells and recognizes single antigenic specificity whose expression is up-regulated in virus-transformed rat fibroblast.

Authors:  A Haque; M Chamekh; J Cornelis; A Capron; S Haque
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

Review 7.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 8.  The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

Authors:  L Schofield
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

9.  Ring-infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor-alpha production.

Authors:  S Picot; F Peyron; P Deloron; C Boudin; B Chumpitazi; G Barbe; J P Vuillez; A Donadille; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

10.  Reactivity profile of human anti-82-kilodalton rhoptry protein antibodies generated during natural infection with Plasmodium falciparum.

Authors:  R F Howard; J B Jensen; H L Franklin
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.